Prenetics Global (PRE) Earnings Analysis
Prenetics Global (PRE) next reports earnings on 2026-09-11, consensus EPS -0.48 USD. Last quarter (2026-06-10) it missed with EPS -1.36 USD vs -0.49 USD est (-177.6%). It has beaten estimates in 3/7 recent quarters (43%). Trailing P/E -4.77.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does PRE next report earnings?
| Next earnings date | 2026-09-11 |
|---|---|
| Consensus EPS estimate | -0.48 USD |
| Revenue estimate | 0.05B |
PRE earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-06-10 | -1.36 USD | -0.49 USD | -177.6% | Miss |
| 2026-02-18 | -0.27 USD | -0.49 USD | +44.9% | Beat |
| 2025-11-10 | -0.41 USD | -0.55 USD | +25.5% | Beat |
| 2025-09-12 | -0.82 USD | -0.71 USD | -15.5% | Miss |
| 2025-06-12 | -0.8 USD | -0.77 USD | -3.9% | Miss |
| 2025-03-05 | -1.28624 USD | -0.72 USD | -78.6% | Miss |
| 2024-11-27 | -0.88 USD | -0.93 USD | +5.4% | Beat |
Beat rate: 3/7 (43%) over reported quarters with consensus data.
PRE valuation and analyst view
| Trailing P/E | -4.77 |
|---|---|
| Trailing EPS | -4.18293 USD |
| Price / book | 3.07 |
| Dividend yield | 0.00% |
| Market cap | 0.38B |
| Analyst consensus | Buy (2 buy / 0 hold / 0 sell) |
| Avg price target | 35 USD |
Related research pages
Frequently asked questions
When is Prenetics Global (PRE)'s next earnings date?
Prenetics Global is next scheduled to report on 2026-09-11, with a consensus EPS estimate of -0.48 USD and revenue estimate of 0.05B.
Did PRE beat earnings last quarter?
In its 2026-06-10 report, PRE posted EPS of -1.36 USD versus a -0.49 USD estimate — a miss of 177.6%.
What is PRE's earnings track record?
Over the last 7 reported quarters with consensus data, PRE beat estimates 3 times (43%).
What is PRE's current P/E ratio and EPS?
PRE trades at a trailing P/E of -4.77 on trailing EPS of -4.182934566754453 USD.
What do analysts rate PRE?
Analyst consensus is "Buy" across 2 ratings (0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 35 USD.